HLIB upgrades DKSH to 'buy' due to a potential upside of 20....
HLIB upgrades DKSH to 'buy' due to a potential upside of 20.4%. Core net profit growth expected due to better margin mix in healthcare and lower tax rate, despite decreased revenue.
HLIB Upgrades DKSH to 'buy' With a Target Price of RM5.50
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment